For supply chain security, ‘don’t live in the moment’ - CPHI Frankfurt preview
CPHI caught up with Jim Fries to discuss sustainable supply chains ahead of his CPHI Frankfurt panel discussion
At the core of the pharmaceutical industry is the mission to provide patients with safe, high-quality drugs when they need them. To do this, pharma companies must ensure the timely delivery of their drugs to a potentially global customer base, which requires secure supply chains and a sustainable approach to business.
This will be the subject of the presentation Sustainability, Quality and Supply Chain Integrity: A New View at CPHI Frankfurt this year. In this session, CEO of the nonprofit international consortium Rx-360, Jim Fries will discuss the intersection of sustainability, quality, and supply chain integrity in the post-pandemic era and explore how best practices in one sector can lead to positive changes in the others.
Jim’s session will take place on November 2 – Register for CPHI Frankfurt now.
Jim Fries, Chief Executive Officer, Rx-360
You will be presenting the session Sustainability, Quality and Supply Chain Integrity at CPHI Frankfurt. What can attendees expect to gain from this session?
They will gain a great understanding of how these areas link together. It will leave them thinking about how they can improve in these areas. Every company and organisation is different, my goal is to get them thinking with value points and queries.
The pandemic shone a light on issues in the supply chain and prompted a mass re-evaluation of how to prevent shortages. What advice can you give for promoting supply chain resilience?
Have multiple suppliers and always think ahead. Don’t live in the moment
Why are you attending CPHI Frankfurt this year?
Great opportunity to interact with international colleagues and support the mission of Rx-360 as an international consortium.
We have a packed agenda of content and networking opportunities at this year’s event. What are you most looking forward to?
To be honest, the networking opportunities.
CPHI’s new brand line is ‘At the heart of Pharma’. What does that mean to you?
Understanding what is going on at the root level. Dive deep!
Related News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Pharmapack 2024 - From the Floor
Paris once again welcomes Europe’s leading trade show in pharmaceutical packaging and drug delivery innovation. Join our content team as Pharmapack 2024 opens its doors to leading experts and innovators in pharmaceutical packaging and drug delive... -
News On Track at Pharmapack 2024 - The Track Sponsor interview: BD Pharmaceuticals
January 2024 brings both a new year and Europe’s leading packaging and drug delivery event. Bringing the world’s experts in pharmaceutical packaging together in Paris, France, Pharmapack 2024 brings exciting opportunities to learn and colla... -
News CPHI Pharma Awards 2023 – API Development and Innovation Winners: Snapdragon Chemistry, a Cambrex Company
After another year of impressive nominations for the CPHI Pharma Awards our winners were announced at CPHI Barcelona in October. In this series of interviews, we speak to the teams behind the award-winning projects, concepts, and technologies. -
News PharmaKure gains authorisation for next stage testing on Alzheimer's treatment
Clinical stage pharmaceutical company PharmaKure gains permission from UK authorities to enter into further testing for PK051 for the treatment of patients with mild cognitive impairment associated with Alzheimer's disease. -
News New Novo Nordisk AI hub for drug discovery to open in London, UK
Danish pharmaceutical giant Novo Nordisk will be opening an AI-based research facility in the heart of London to advance drug discovery operations. -
News Navigating the Future: Challenges and Opportunities in Pharma Innovation and Investment – CPHI Barcelona 2023 Roundtable Report
In this comprehensive downloadable report, hear from a range of experts in finance and investment in the pharma industry on what investment trends will be shaping the future of the industry, in Catalonia, and the wider world. -
News BioNTech to begin mRNA vaccine manufacturing in Rwanda by 2025
German biotechnology company BioNTech has stated their intentions to begin production at their mRNA vaccine factory in Rwanda by 2025, which will mark the first foreign mRNA vaccine manufacturing site on the continent of Africa.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance